Mr. Dill is the CEO and Chairman of Wellesley Pharmaceuticals. A graduate of Brown University, he worked for emerging companies in high tech, and real estate management during a successful 40 year career. He assumed the reigns of Wellesley Pharmaceuticals upon the death of his brother David. His focus has been capital raising, building strategic alliances, updating the strategy, and redirecting the team. The original vision still drives the strategic intent of the Company.